Chinese patients with advanced cancer identified 6 themes of important spiritual needs
1. Chinese patients with advanced cancer identified themes such as being treated as normal and...
Read MoreMar 7, 2024
1. Chinese patients with advanced cancer identified themes such as being treated as normal and...
Read MoreMar 7, 2024
1. In a Korean cohort of breast cancer survivors, younger survivors had an increased risk of...
Read MoreMar 3, 2024
Adjuvant chemotherapy after resection of biliary tract cancer doesn’t improve overall survival in patients aged 70 or older compared to observation.
Read MoreMar 2, 2024
MSI-H colorectal cancer patients, after extended immunotherapy, exhibit low recurrence, guiding treatment discussions.
Read MoreMar 2, 2024
Higher BMI at age 18 is linearly associated with increased risk of site-specific cancers in men, underlining the importance of early-life obesity prevention.
Read MoreMar 2, 2024
Inflammatory tongue conditions significantly increase the risk of oral tongue cancers, emphasizing the importance of heightened clinical surveillance.
Read MoreMar 2, 2024
Long-term low-dose aspirin use is associated with slight to moderate reductions in the risk of specific cancers, but not cancer overall.
Read MoreMar 2, 2024
In metastatic NSCLC patients receiving immunotherapy, racial/ethnic groups have similar outcomes; ECOG performance status correlates with survival.
Read MoreMar 2, 2024
Two decades of annual low-dose CT screening in the I-ELCAP cohort reveal a sustained 80% lung cancer-specific survival rate, updating the cure rate.
Read MoreFeb 24, 2024
1. Tabelecleucel provided clinical improvement in patients with EBV-related post-transplant...
Read MoreFeb 24, 2024
1. Among United States veterans of the Iraq and Afghanistan wars, the experience of a moderate,...
Read MoreFeb 23, 2024
1. Having a greater number of unmet social needs was associated with lower utilization of...
Read MoreFeb 20, 2024
1. The clinical benefit rate was 32% in the 9 mg group and 29% in the 18 mg group. 2. Grade 3 or...
Read MoreFeb 20, 2024
This phase 3 multicenter trial demonstrated the efficacy and safety of tabelecleucel in patients...
Read MoreFeb 15, 2024
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care...
Read MoreFeb 13, 2024
1. The change of uNTx/uCr (a marker of bone resorption) was within the equivalence margin in the...
Read MoreFeb 9, 2024
1. In patients diagnosed with stage III or IV non-small cell lung cancer (NSCLC), immune...
Read MoreFeb 6, 2024
1. Adding subcutaneous daratumumab to VRd (bortezomib, lenalidomide, and dexamethasone)...
Read MoreFeb 6, 2024
1. The objective response rate was 28% with a complete response of 5.6% and a partial response of...
Read MoreFeb 1, 2024
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read More